Sébastien Anguille

13PUBLICATIONS

61CO-AUTHORS

Haematological tumoursPredictive and prognostic markersMolecular targetsGene and molecular therapyLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 29, 2026

Proteomics in Acute Myeloid Leukemia: Current Applications in Precision Medicine and Targeted Immunotherapy.

|Jun 19, 2026

The search for safe and effective CAR-T targets in AML.

|Sep 24, 2025

Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.

Elise R A Pennings, Anne M Spanjaart, Frederick W Thielen

|Sep 15, 2025

Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.

Daniel Pollyea, Tessa Kerre, Dries Deeren

|Feb 26, 2025

Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells.

Caroline Lonez, Jennifer Bolsée, Fanny Huberty

|Oct 17, 2024

Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives.

Bert Heyrman, Stef Meers, Sélim Sid

Pageof 3

Frequent Collaborators

Eva Lion

Bert Heyrman

Diana Campillo-Davo

Donovan Flumens

Florian Van Oers

Laurens Krekelbergh

Caroline Lonez

Eva De Backer

Gils Roex

Hans De Reu

Frequent Collaborators

Eva Lion

Bert Heyrman

Diana Campillo-Davo

Donovan Flumens